top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
3D Printing of Pharmaceuticals and Drug Delivery Devices
3D Printing of Pharmaceuticals and Drug Delivery Devices
Autore Lamprou Dimitrios A
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (436 p.)
Soggetto topico Medicine
Soggetto non controllato digital pharmacy
fused deposition modeling 3D printing
modified drug release
personalized medicines
telemedicine
three dimensional printing
additive manufacturing
3D printed drug products
printlets
personalised medicines
personalized pharmaceuticals
multiple units
spheroids
beads
acetaminophen
3D printing
fused filament fabrication
lignin
antioxidant materials
wound dressing
modified release
filament extrusion
fused layer modeling
theophylline
high API load
three-dimensional printing
fixed-dose combinations
tablets
multiple-layer dosage forms
stereolithography
vat polymerisation
fused deposition modeling
polylactic acid
chemical modification
MTT assay
biofilm formation
warfarin
semisolid extrusion 3D printing
inkjet printing
orodispersible film
oral powder
pediatric
hospital pharmacy
personalized medicine
on-demand manufacturing
drug delivery
micromedicine
drug development
micro-swimmer
micro-implant
oral dosages
microneedle
high-precision targeting
controlled release
geometry
resolution
feature size
release profile
vascularization
digital light processing technology
neural networks
optimization
prediction
FMD
pregabalin
gastric floating
complex structures
patient-specific
structural design
gums
Fused Deposition Modeling 3D Printing
processing parameters
pharmaceutical quality control
hot-melt extrusion
solid dosage forms
3D printed oral dosage forms
sustained drug release tablets
photopolymerization
paracetamol (acetaminophen)
aspirin (acetylsalicylic acid)
amorphous solid dispersion
poor solubility
fixed dose combination
stencil printing
pharmacoprinting
orodispersible discs
orodisperible films
floating systems
pulsatile release
chronotherapeutic delivery
wound-healing
3D bio-printing
pectin
propolis
cyclodextrin
3D bio-inks
fused deposition modelling
extrusion
vaginal meshes
mechanical properties
drug release
anti-infective devices
pelvic organ prolapse
stress urinary incontinence
gastro-retentive floating system
dissolution kinetics
implantable devices
subcutaneous
biodegradable
prolonged drug delivery
polymers
pharmaceuticals
extrusion-based 3D printing
fused deposition modeling (FDM)
pressure-assisted microsyringe (PAM)
materials
process
3D bioprinting
polymeric ink
pseudo-bone
implantable scaffold
computer-aided design (CAD) design
bioprinting
computer-aided design (CAD)
pharmaceutics
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557780703321
Lamprou Dimitrios A  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Hurdles for Phage Therapy (PT) to Become a Reality
Hurdles for Phage Therapy (PT) to Become a Reality
Autore Brüssow Harald
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (484 p.)
Soggetto non controllato alginate
abortive infection
bacterial resistance
bacteriophages
ATMP
MALDI-MS
adaptation
Bacteriophage
horizontal gene transfer
adaptive immunity
co-evolution
Listeria ivanovii
personalised medicines
pH stability
phage-human host interaction
vB_SauM-fRuSau02
antimicrobial resistance
phagodisinfection
biofilm
capsule depolymerase
animal model
phage cocktails
Enterococcus
cases report
zoonosis
resistance
magistral formula
experimental therapy
Belgium
phage therapy
E. faecalis
nontraditional antibacterial
industrial phage application
Democratic Republic of the Congo
OrthoMCL
Germany
high-throughput sequencing
antimicrobial
infection
antibiotic therapy
Kayvirus
phages
Twortlikevirus
bacterial disease
human host
Pseudomonas aeruginosa
phage
multidrug-resistant bacteria
bacterial infection
Salmonella Typhi
rhamnopolysaccharide
compassionate use
crop production
compounding pharmacy
antimicrobial resistance (AMR)
best practices
bacteriophage efficacy
phage sensitivity
antibiotic-resistance
antibiotic
lysins
PTMP
Escherichia coli
typhoid fever
patent landscape
phage preparation
innate immunity
anti-phage antibodies
immunology
Staphylococcus aureus
global health
clinical trial
adsorption
Brussels
phage-resistance
Galleria mellonella
science communication
history of science
virus-host interactions
foodborne illness
prophage
resistance management
biofilms
IND
immunomodulation
frequency of resistance
capsule
gastrointestinal tract
phage-host interactions
disinfection
production
bacteriophage therapy
bacteriophage
Staphylococcus
magistral preparation
extended-spectrum beta lactamases (ESBL)
Viral proteins
antibiotic resistance
genomics
phage biocontrol
therapy
target selection
viral genomes
evolution
pharmaceutical paradigm shift
personalized medicine
pharmaceutical legislation
food safety
regulation
virulence
developing countries
infectious disease
regulatory framework
sustainable agriculture
Klebsiella pneumoniae
ISBN 3-03921-392-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Hurdles for Phage Therapy
Record Nr. UNINA-9910367566603321
Brüssow Harald  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui